Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for lisdexamfetamine dimesylate

  1. Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

    This evidence summary has been updated and replaced by NICE guideline NG87.

    Evidence summary
    Published
    7 May 2013